Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda Pring

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Oncogene|March 16, 2002
TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrestIan C Paterson, Maria Davies, Andrea Stone, et al.
Head & Neck|January 8, 2021
Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort studyKate Ingarfield, Alex D McMahon, Katrina Hurley, et al.
Elife|April 12, 2023
Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomizationMark Gormley, Tom Dudding, Steven J Thomas, et al.
Palliative Medicine|February 28, 2020
Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the 'Head and Neck 5000' population-based prospective clinical cohort studyCatriona R Mayland, Kate Ingarfield, Simon N Rogers, et al.
Cancer Epidemiology|February 5, 2022
Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosisJulia Simon, Nicole Brenner, Sibylle Reich, et al.
Journal of Clinical Pathology|December 6, 2023
Macroscopic examination of pathology specimens: a critical reappraisalMurali Varma, Laura C Collins, Runjan Chetty, et al.
BMC Cancer|December 19, 2014
Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000Andrew Robert Ness, Andrea Waylen, Katrina Hurley, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
The Lancet. Digital Health|April 16, 2026
Joint probability framework for the development and validation of a prognostic model for the conditional outcome of quality of life: a retrospective study in historical European cohorts of survivors of head and neck cancerMauricio Moreira-Soares, Erlend I F Fossen, Aritz Bilbao-Jayo, et al.
Oral Oncology|September 18, 2018
DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survivalSrikant Ambatipudi, Ryan Langdon, Rebecca C Richmond, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Oncogene|March 16, 2002
TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrestIan C Paterson, Maria Davies, Andrea Stone, et al.
Head & Neck|January 8, 2021
Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort studyKate Ingarfield, Alex D McMahon, Katrina Hurley, et al.
Elife|April 12, 2023
Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomizationMark Gormley, Tom Dudding, Steven J Thomas, et al.
Palliative Medicine|February 28, 2020
Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the 'Head and Neck 5000' population-based prospective clinical cohort studyCatriona R Mayland, Kate Ingarfield, Simon N Rogers, et al.
Cancer Epidemiology|February 5, 2022
Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosisJulia Simon, Nicole Brenner, Sibylle Reich, et al.
Journal of Clinical Pathology|December 6, 2023
Macroscopic examination of pathology specimens: a critical reappraisalMurali Varma, Laura C Collins, Runjan Chetty, et al.
BMC Cancer|December 19, 2014
Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000Andrew Robert Ness, Andrea Waylen, Katrina Hurley, et al.
Nature Communications|November 28, 2020
A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancerMark Gormley, Tom Dudding, Eleanor Sanderson, et al.
The Lancet. Digital Health|April 16, 2026
Joint probability framework for the development and validation of a prognostic model for the conditional outcome of quality of life: a retrospective study in historical European cohorts of survivors of head and neck cancerMauricio Moreira-Soares, Erlend I F Fossen, Aritz Bilbao-Jayo, et al.
Oral Oncology|September 18, 2018
DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survivalSrikant Ambatipudi, Ryan Langdon, Rebecca C Richmond, et al.
Pageof 5